protein

Recombinant Human GM-CSF GMP Protein, CF

215-GMP-050

50 ug (also 1 mg)

1322 USD

215-GMP-050

Recombinant Human GM-CSF GMP Protein, CF

50 ug (also 1 mg)

The Recombinant Human GM-CSF GMP Protein, CF from R&D Systems is derived from E. coli. The Recombinant Human GM-CSF GMP Protein, CF has been validated for the following applications: Bioactivity.

GM-CSF

Proteins and Enzymes

Lyophilized from a 0.2 ╡m filtered solution in PBS.

Unconjugated

Human

14 kDa, reducing conditions

14.5 kDa

CSF2

Measured in a cell proliferation assay using TF-1 human erythroleukemic cells. Kitamura, T. et al . (1989) J. Cell Physiol. 140 :323. The ED50 for this effect is 6-30 pg/mL. The specific activity of recombinant human GM-CSF is 1.0 x 107 IU/mg, which is calibrated against the human GM-CSF WHO International Standard (NIBSC code: 88/646).

<0.10 EU per 1 ╡g of the protein by the LAL method.

Recombinant Human GM-CSF GMP Protein Bioactivity

P04141.1

Bioactivity

E. coli -derived human GM-CSF protein Ala18-Glu144 Produced using non-animal reagents in an animal-free laboratory. Manufactured and tested under cGMP guidelines.

E. coli

Animal-Free.

1322 USD

Animal-Free.

colony stimulating factor 2 (granulocyte-macrophage), Colony-stimulating factor, CSF, CSF2, CSF-2, GMCSF, GM-CSF, GMCSFgranulocyte-macrophage colony-stimulating factor, granulocyte-macrophage colony stimulating factor, MGC131935, MGC138897, Molgramostim, molgramostin, sargramostim

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. A minimum of 12 months when stored at <= -20 ░C as supplied. Refer to lot specific COA for the Use by Date. 1 month, 2 to 8 ░C under sterile conditions after reconstitution. 3 months, <= -20 ░C under sterile conditions after reconstitution.